table-1-trials-on-gh-ghrh-analogue-or-gh-secretago->table-2-selected-currently-active-or-recently-comp Content Directory

Table 1 Trials on GH, GHRH analogue or GH secretagogue therapy in obesity
Table 1 Upper oesophageal sphincter kinetics
Table 1 Use of melanocortin antagonists in rodent models of cachexia
Table 1: Users of NSO’s statistical data
Table 1 UTI in series of patients with nonrefluxing hydronephrosis or PNRM*
Table 1. Vaccination strategies – Advantages vs disadvantages
Table 1. Virally implicated diseases.
Table 1. Water Use in Indiana, 1990, 1995 and 2000.
Table 1. Water Use in Indiana, 1990, 1995 and 2000.
Table 10-1. Chapter 10 Outline, p. 307
Table 10.1 Levels of analysis in the study of animal behavior
Table 10-1, p. 207
Table 10
Table 10
Table 11-1. Chapter 11 Outline (Kerbo, p. 343)
Table 11.1 Norms and sanctions
Table 11-1, p. 379
Table 11-1, p. 379
TABLE 11.1 Summary of Casting Processes
The Identification of Genetic Hyperlipidemias Robert E.Ferrell , Ph.D Department of Human Genetics,
Table 12.1: Cash Flows to a Cash and Carry Trading Strategy
Table 12.1: Cash Flows to a Cash and Carry Trading Strategy
Table 12-1. Chapter 12: Social Mobility, Outline
Table 12.1: Halogenation of Benzene
TABLE 12-1 Solution for Annual Revenue (Example 12-1)
Table 12.1 Types of teams and their outputs
SEVERE WEATHER
Table 13-1
Table 13.1 Page 218
Table 13.1 Page 218
Table 13.2: Cash Flow to a Fixed Rate Loan with Coupon C, Principal L, and maturity date T.
Table 1307.C – Physical Depreciation
Table 1307.C – Physical Depreciation
Table 135.1 -- Effects of aging on the cardiovascular system .
TABLE 14-1 Job Offer Selection Problem
TABLE 14-1 Job Offer Selection Problem
Table 14.2
Table 15-1, p.549
Table 15-1, p. 612
Table 15-1, p. 612
Table 15-1 ( Revised 27/1, 2014)
Table 16.1, p. 800
Table 16.2
TABLE 16: Chronology of pesticide development (Stephenson and Solomon, 1993)
Table 17-1 Psychoanalysis
Table 17-1 Psychoanalysis
Table 1Application Subset Taxonomy
Table 1S. Summary of high-resolution mass spectra of nucleoside derivatives.
Table 2.
Table 2
Table 2
Table 2.1
Table 2.1.1: New Transplant Rate per million population (pmp), 1998-2005
Table 2-1 Four Features of Gert’s Moral System
Table 2.1: Number of Community Hospitals, (1) 1981 – 2005
Table 2.1: Number of Community Hospitals, (1) 1981 – 2006
Table 2.1: Number of Community Hospitals, (1) 1989 – 2009
Table 2-1: Old Economy vs. New Economy
Table 2.1 Postulates and Theorems of Boolean Algebra
Table 2.1
Table 2.1. Summary of theories and perspectives that influence approaches to teaching young children
Table 2-4 Static Analysis of C & B Chemical Company (50,000 pounds of output)
TABLE 2.4 Unemployment and Long-Term Unemployment, Selected European and North American Countries, 2003
Table 2 AJCC/UICC staging classification for serum tumor markers in testis cancer
Table 2 Anatomical and functional neuroimaging techniques commonly used in evaluation of NPSLE
Table 2 Annual prostate cancer MRSI milestones on 1.5 T scanners, 2000–2010
Table 2 Anti-TNF agents for treatment of postoperative recurrence of Crohn’s disease
Table 2 Characteristic abnormalities found in different diagnostic tests
Table 2 Comparison of damage accrual over time in pSLE and aSLE patients
Table 2: Correlation between age and readiness to change
Table 2: Cost Components of each Service (% of total cost)
Table 2. Currently Funded Training Positions
Table 2 Deregulated miRNAs, potential targets and functions in oesophageal squamous carcinoma
Table 2 Differentiating characteristics of GBS, GBS-TRF, A‑CIDP and CIDP
Table 2 Distinguishing features of the subtypes of HTLV-1-associated ATLL
Table 2. Entry Averages and First Year Performance, StFX, 1998-2004 Average
Table 2. Estimated Model Parameters
Table 2: Foreign indebtedness of the CR
Table 2: Genes expressed only in 0 m M Al and also expressed in the YEPD (yellow array)
TABLE 2 Genetic, biochemical and molecular heterogeneity in BLS
Table 2 Genetic disorders with a predisposition for brain tumors
Table 2 Genetic modifications in mice that worsen cartilage breakdown in PTOA models
Table 2 Genetic mutations associated with disorders of sex development
Table 2 Genotype–phenotype correlations in VHL disease
Table 2 Improved outcomes with addition of ADT to radiation treatment
Table 2 Incidence of inflammatory, undifferentiated and rheumatoid arthritis
Table 2 Key differences between two major subtypes of primary aldosteronism
Table 2 Kidney-specific intervention targeting EGFR
Table 2. Leukocyte enrichment as assessed by flow cytometry.
Table 2. Mean ( ±SEM) percent BOLD signal change for tones relative to silent trials in PAC.
Table 2 MiRNAs as prognostic and predictive markers in advanced and metastatic cancers
Table 2. Mode of delivery ( N=276 )
Table 2 Molecular-targeted therapies in clinical trials
Table 2. NAME-RELATED MODELING AND DIAGNOSTIC STUDIES
Table 2 Neurophysiological abnormalities in the nociceptive sensory domain in PD
Table 2 Obligatory DCDD no-touch times worldwide
Table 2 Ongoing clinical trials of active amyloid‑β immunotherapies
Table 2 Outcomes of RARC with ICUD
Table 2 Oxidative stress in infertile men with or without* varicocele
Table 2. Participant A B C D E
Table 2 Perinatal outcomes in the HAPO cohort*
Table 2 PFS and overall survival for each DLBCL molecular subtype
Table 2. Progreso boys and girls. Abbreviations as in Table 1
Table 2 Published RCTs of therapeutics in LVV, excluding trials of steroid dosing alone
Table 2 Randomized ICH clinical trials 2000–2010
Table 2 Recommended measures to be included in future studies of RA‑ILD
Table 2. Relationship between the root of lower third molar and mandibular canal in CT images
Table 2 Results from twin studies of irritable bowel syndrome
Table 2 Results of repeated-measures ANOVAs analyzing growth by condition
Table 2 Risk of progression to HGD/OAC based on Barrett oesophagus length
Table 2 Risk stratification for HBV reactivation
Table 2: ROC curve: Area under the curve ( AUC) DeLong et al., 1988 Binomial exact
Table 2. Scattering parameter comparisons

Browse slideshows:
a
b
c
d
e
f
g
h
i
j
k
l
m
n
o
p
q
r
s
t
u
v
w
x
y
z
0
1
2
3
4
5
6
7
8
9